ArticleInternational journal of clinical and experimental pathology2014
Double CEBPA mutations are prognostically favorable in non-M3 acute myeloid leukemia patients with wild-type NPM1 and FLT3-ITD.
Xiang-Mei Wen et al.PubMed ↗Full text ↗
No numbers read from the abstract.
30 papers cite it
this papertrialcites it